---
figid: PMC11338244__mmr-30-04-13304-g03
figtitle: Methylation of the PI3K/AKT/mTOR signaling pathway on tamoxifen
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11338244
filename: mmr-30-04-13304-g03.jpg
figlink: /pmc/articles/PMC11338244/figure/F4
number: F4
caption: Effects of methylation of the PI3K/AKT/mTOR signaling pathway on tamoxifen.
  The methylation-induced activation of the PI3K/AKT/mTOR signaling pathway leads
  to tamoxifen resistance. PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
  3,4,5-trisphosphate; IRS, insulin receptor substrate; PTEN, phosphatase and tensin
  homolog; PDK1, 3-phosphoinositide-dependent protein kinase 1; TSC, tuberous sclerosis
  complex; mTORC1, target of rapamycin complex 1; H3K4, histone H3 lysine 4; MLL,
  mixed-lineage leukemia protein; SALL2, Sal-like protein 2; ZDHHC22, Zinc finger
  DHHC-type containing 22; METTL3, methyltransferase-like 3; AK4, adenylate kinase
  4; ATF3, activating transcription factor-3; EZH2, enhancer of zester homolog 2;
  GDF15, Growth differentiation factor-1; DOK7, downstream of kinase 7; PITX2, paired-like
  homeodomain transcription factor 2; ERRFI1, ERBB receptor feedback inhibitor 1;
  TROP2, tumor-associated calcium signal transducer 2
papertitle: Crosstalk of methylation and tamoxifen in breast cancer (Review)
reftext: Jin Shen, et al. Mol Med Rep. 2024 Oct;30(4).
year: '2024'
doi: 10.3892/mmr.2024.13304
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos
keywords: methylation | tamoxifen | breast cancer | resistance
automl_pathway: 0.9394671
figid_alias: PMC11338244__F4
figtype: Figure
redirect_from: /figures/PMC11338244__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11338244__mmr-30-04-13304-g03.html
  '@type': Dataset
  description: Effects of methylation of the PI3K/AKT/mTOR signaling pathway on tamoxifen.
    The methylation-induced activation of the PI3K/AKT/mTOR signaling pathway leads
    to tamoxifen resistance. PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
    3,4,5-trisphosphate; IRS, insulin receptor substrate; PTEN, phosphatase and tensin
    homolog; PDK1, 3-phosphoinositide-dependent protein kinase 1; TSC, tuberous sclerosis
    complex; mTORC1, target of rapamycin complex 1; H3K4, histone H3 lysine 4; MLL,
    mixed-lineage leukemia protein; SALL2, Sal-like protein 2; ZDHHC22, Zinc finger
    DHHC-type containing 22; METTL3, methyltransferase-like 3; AK4, adenylate kinase
    4; ATF3, activating transcription factor-3; EZH2, enhancer of zester homolog 2;
    GDF15, Growth differentiation factor-1; DOK7, downstream of kinase 7; PITX2, paired-like
    homeodomain transcription factor 2; ERRFI1, ERBB receptor feedback inhibitor 1;
    TROP2, tumor-associated calcium signal transducer 2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - NRAS
  - PTEN
  - AK4
  - METTL3
  - PDK1
  - PDPK1
  - ATF3
  - AKT1
  - AKT2
  - AKT3
  - SALL2
  - CDKN2A
  - H3P10
  - GDF15
  - TSC1
  - CCL26
  - TSC2
  - DOK7
  - PITX2
  - RHEB
  - RHEBP1
  - ERRFI1
  - MTOR
  - RPTOR
  - ZDHHC22
  - TACSTD2
  - KMT2C
  - H19
  - H1-9P
  - BECN1
  - EZH2
  - PIP3
---
